Search
Filters
Clear All
  • 10

Phase

  • 1
  • 1
  • 1
  • 7
  • 9
  • 2

Found 10 lauren-perrey-moore trials

A listing of lauren-perrey-moore medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Dominantly Inherited Alzheimer Network (DIAN)

M
Martin Farlow, MD
18 years - 100 years
Accepts healthy volunteer
All genders
Dominantly inherited Alzheimer's disease (AD) represents less than 1% of all cases of AD and is an important model for study because the responsible mutations have known biochemical consequences that are believed to underlie the pathological basis of the disorder. The overall purpose of this research is to understand the …
Learn More

Study on a Handheld Device for Brain Health Check

S
Sergiu Abramovici
18 years - 100 years
All genders
Observational
This study investigates a handheld, non-invasive electro-diagnostic device for use by healthcare providers. The purpose of this study is to assist in clinical decision-making and expedite patient care, particularly in areas with limited resources. The device is designed to help identify the location and nature of neurological lesions by analyzing …
Learn More

Alnylam ALN-APP-001: Phase I, placebo-controlled trial of ALN-APP in participants with Early-Onset Alzheimer’s disease

J
Jared Brosch, MD
18 years - 100 years
All genders
Phase 1
Interventional
Who is Eligible Ages 18+ Must have had symptoms of Alzheimer’s disease prior to age 65 Diagnosis of Alzheimer’s disease Must be able to complete MRI Must be able to tolerate lumbar puncture No history of seizures, stroke or cancer in the last 5 years What is Involved In-person visits …
Learn More

MRI Techniques in Brain Bleeding

J
Jason Mackey
18 years - 100 years
All genders
This study investigates the use of advanced MRI techniques to predict outcomes in patients who have experienced an intracerebral hemorrhage (ICH). Intracerebral hemorrhage is a type of stroke caused by bleeding within the brain. The study aims to understand how these advanced imaging techniques can show changes in brain function …
Learn More

Studying Huntington's Disease: Observing Participants

C
Christopher James
100 years or below
Accepts healthy volunteer
All genders
This study investigates Huntington's disease (HD), a condition that affects the brain and causes movement, cognitive, and psychiatric disorders. The purpose of this study is to gather data on people with HD and their family members to better understand the disease. An observational study is a type of research study …
Learn More

Parkinson’s Foundation PD GENEration Genetic Registry

S
S. Elizabeth Zauber
18 years - 100 years
All genders
Who is EligibleAges 18+Diagnosis of Parkinson’s diseaseWillingness to undergo genetic testingWhat is InvolvedIn person at IUH Neuroscience Center or kit can be mailed to participant’s homeGenetic testing occurs via buccal swab or blood draw in clinic or at home, participants receive genetic counseling 
Learn More

Nicotinic Acid for the treatment of Alzheimer's Disease Protocol Type: Interventional

J
Jared Brosch, MD
60 years - 85 years
All genders
Phase 1/2
What is the purpose of this study?The primary objective of this study is to collect data on the penetration of commercially available, FDA approved, extended-release niacin into the spinal fluid. One dose of 500 mg nicotinic acid will be used (in addition to placebo) to build a dose response curve …
Learn More

Investigational Medication for ALS: Expanded Access Program

C
Cynthia Bodkin, MD
18 years - 100 years
All genders
This study investigates an Expanded Access Program for people with Amyotrophic Lateral Sclerosis (ALS). ALS is a disease that affects nerve cells in the brain and spinal cord, leading to loss of muscle control. The purpose of this program is to provide access to an investigational medication for ALS patients …
Learn More

Development of trial-ready cohort to facilitate rapid enrollment into Alzheimer’s trials for participants with Down Syndrome (Trial Ready Cohort—Down Syndrome (TRC-DS)

J
Jill Fodstad
35 years - 55 years
All genders
Interventional
Who is Eligible Ages 35-55 Must be willing to complete PET scan What is Involved Onsite visits at the IUH Neuroscience Center Visits at the IUH Neuroscience Center every 16 months Compensation Compensation available via payment card for each completed appointment
Learn More

Study on Long-Term Effects of an Investigational Medication for Myotonic Dystrophy Type 1 (DM1)

A
Adam Comer
16 years - 17 years
All genders
Phase 3
Interventional
This study investigates the long-term effects of an investigational medication for Myotonic Dystrophy Type 1 (DM1). DM1 is a genetic disorder that affects muscle function and can cause muscle weakness and stiffness. This study aims to understand how the investigational medication affects people with DM1 over a long period.Participants will …
Learn More